Nectar Lifesciences has informed Karvy Computershare Private Limited (KCPL), the Registrar & Share Transfer Agent of the company, vide their e-mail dated 29th November, 2018 that pursuant to Order of the Hyderabad Bench of the National Company Law Tribunal (NCLT), the operations of KCPL have been transferred to Karvy Fintech with effect from 17th November, 2018. The company has further informed that pursuant to the NCLT Order, all the existing agreements to which KCPL is a party including the agreements entered into by the company shall be in full force and vest with Karvy Fintech and all statutory licenses held by the transferor company, KCPL, whether statutory or otherwise, shall also transferred to Karvy Fintech on the same terms and conditions as are available to KCPL.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.70 |
| Dr. Reddys Lab | 1232.00 |
| Cipla | 1229.60 |
| Zydus Lifesciences | 915.45 |
| Lupin | 2332.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: